TNFRSF17 and Miyoshi myopathy: These antibodies effectively bridge T cells and MM cells by simultaneously binding CD3 on T cells and specific antigens on MM cells, such as BCMA, CD38, Fc receptor-homolog 5 (FcRH5), or GPRC5D.